Acadia Pharma (ACAD) – Hot FDA News
-
Acadia Pharma (ACAD) Reports Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin
-
Acadia Pharma (ACAD) Resume Trading, Down 32%
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ACAD Stock Lookup